ERT

ERT (eResearch Technology) is a global data and technology company dedicated to minimizing uncertainty and risk in clinical trials so its customers can move forward with confidence. With nearly 50 years of clinical and therapeutic expertise, ERT balances knowledge of what works with a vision for what’s next, allowing it to adapt without compromising standards.Backed by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, optimize sites, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. In 2019, 75% of FDA drug approvals were based on studies supported by ERT. Pharmaceutical companies, biotech firms, and CROs have relied on ERT solutions across 16,000 studies, impacting over 5 million patients to date. By identifying trial risks before issues arise, ERT empowers its clients to deliver clinical treatments to patients quickly and confidently.